Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

general

Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)

Centers

Active Trials

—

Cancer Funding

Top Centers for Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8(21)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	71.7
2	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	71.7
3	University of Illinois Cancer CenterChicago, IL High-Volume Research Center	High-Volume Research Center	2	—	71.7
4	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
5	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
6	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
7	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
8	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
9	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
10	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	54.5
11	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.5
12	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	54.5
13	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	54.5
14	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	54.5
15	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	54.5
16	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	54.5
17	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	35.2
18	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive		—	—	35.2
19	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	35.2
20	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR		—	—	35.2
21	Louisiana Cancer Research CenterNew Orleans, LA		—	—	35.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →